Benlysta is the first prescription medication designed specifically to treat adults with active systemic lupus erythematosus sle it was approved for the treatment of lupus by the us food and drug administration fda on march 9 2011. Benlysta is a prescription medication used to treat adults with active systemic lupus erythematosus sle or lupus who are receiving other lupus medicines it is not known if benlysta is safe and effective in people with severe active lupus nephritis or severe active central nervous system lupus and it has not been studied in combination with . Officially known as systemic lupus erythematosus sle lupus is an autoimmune disease its relatively common affecting about one in 1000 people its relatively common affecting about one in . Benlysta belimumab reduces disease activity relapses and the need for corticosteroids in patients with a high degree of systemic lupus erythematosus sle disease activity according to a new analysis of a phase 3 clinical trial. Reviews for belimumab to treat systemic lupus erythematosus sort by most recent most helpful highest rating lowest rating member rank time on medication benlysta belimumab i am 69 years old and was diagnosed with sle 2 1 2 years ago
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )